StockData
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. (RKDA) stock

RKDANasdaqBeveragesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.19−0.00 (-2.01%)

Close on Nov 17, 2026Market cap $457.03KP/E –Yield –

Arcadia Biosciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Arcadia Biosciences's pe ratio was 1.5× on Jan 31, 2022.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Jan 31, 20221.5×−0.3
2021Dec 31, 20211.8×–

More Arcadia Biosciences figures

See a number that looks wrong?